US Bancorp’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

US Bancorp’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-263	Closed	-$1.18K	–	4151
2023 Q4	$1.18K	Hold	263	–	–	﹤0.01%	3786
2023 Q3	$1.59K	Sell	263 -1	-0.4%	-$10	﹤0.01%	3698
2023 Q2	$3.23K	Hold	264	–	–	﹤0.01%	3587
2023 Q1	$3.78K	Hold	264	–	–	﹤0.01%	3614
2022 Q4	$3.95K	Hold	264	–	–	﹤0.01%	3596
2022 Q3	$10K	Hold	264	–	–	﹤0.01%	3385
2022 Q2	$20K	Hold	264	–	–	﹤0.01%	3058
2022 Q1	$13K	Hold	264	–	–	﹤0.01%	3302
2021 Q4	$18K	Hold	264	–	–	﹤0.01%	3182
2021 Q3	$38K	Buy	+264	New	+$80.1K	﹤0.01%	2787

US Bancorp's MDVL Position: Q1 2024 in Review

US Bancorp sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 263 shares — an estimated $1.18K sold.

US Bancorp first reported a position in MDVL in Q3 2021 and held it in 10 quarters. The position peaked at $38K in Q3 2021. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

US Bancorp reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
US Bancorp sold 263 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $1.18K.
US Bancorp first reported a position in MedAvail Holdings, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
US Bancorp's MedAvail Holdings, Inc. Common Stock position peaked at $38K in Q3 2021.
1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on US Bancorp's 13F filing for Q1 2024, filed 8 May 2024.